{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:06:40Z","timestamp":1773234400054,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,8,5]],"date-time":"2012-08-05T00:00:00Z","timestamp":1344124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s10067-012-2035-z","type":"journal-article","created":{"date-parts":[[2012,8,4]],"date-time":"2012-08-04T07:15:37Z","timestamp":1344064537000},"page":"1403-1405","source":"Crossref","is-referenced-by-count":18,"title":["Risedronate-associated scleritis: a case report and review of the literature"],"prefix":"10.1007","volume":"31","author":[{"given":"Iman","family":"Hemmati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Wade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kelsall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,5]]},"reference":[{"issue":"2","key":"2035_CR1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2165\/00002018-200629020-00005","volume":"29","author":"BA Barrera","year":"2006","unstructured":"Barrera BA, Wilton L, Harris S, Shakir SA (2006) Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in England. Drug Saf 29(2):151\u2013160","journal-title":"Drug Saf"},{"issue":"8842","key":"2035_CR2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0140-6736(93)93029-Z","volume":"341","author":"ES Siris","year":"1993","unstructured":"Siris ES (1993) Bisphosphonates and iritis. Lancet 341(8842):436\u2013437","journal-title":"Lancet"},{"issue":"6","key":"2035_CR3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/IAE.0b013e31816576ef","volume":"28","author":"DD French","year":"2008","unstructured":"French DD, Margo CE (2008) Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort. Retina 28(6):889\u2013893","journal-title":"Retina"},{"key":"2035_CR4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/107999003322558782","volume":"23","author":"G Dicuonzo","year":"2003","unstructured":"Dicuonzo G, Vincenzi B, Santini D et al (2003) Fever after zoledronic acid administration is due to increase in TNF- and IL-6. J Interferon Cytokine Res 23:649\u2013654","journal-title":"J Interferon Cytokine Res"},{"issue":"12","key":"2035_CR5","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3899\/jrheum.080273","volume":"35","author":"F Banal","year":"2008","unstructured":"Banal F, Briot K, Ayoub G, Dougados M, Roux C (2008) Unilateral anterior uveitis complicating zoledronic acid therapy in prostate cancer. J Rheumatol 35(12):2458\u20132459","journal-title":"J Rheumatol"},{"issue":"15","key":"2035_CR6","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0025-7753(02)72464-0","volume":"118","author":"G Vi\u00f1as","year":"2002","unstructured":"Vi\u00f1as G, Oliv\u00e9 A, Holgado S, Crsosta J (2002) Episcleritis secondary to risedronate. Med Clin (Barc) 118(15):598\u2013599, Review. In Spanish","journal-title":"Med Clin (Barc)"},{"issue":"2","key":"2035_CR7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30(2):239\u2013245","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"2035_CR8","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00198-005-1986-1","volume":"16","author":"BA Barrera","year":"2005","unstructured":"Barrera BA, Wilton L, Harris S, Shakir SA (2005) Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England. Osteoporos Int 16(12):1989\u20131998","journal-title":"Osteoporos Int"},{"issue":"10","key":"2035_CR9","first-page":"1015","volume":"56","author":"M McKague","year":"2010","unstructured":"McKague M, Jorgenson D, Buxton KA (2010) Ocular side effects of bisphosphonates: a case report and literature review. Can Fam Physician 56(10):1015\u20131017","journal-title":"Can Fam Physician"},{"issue":"3","key":"2035_CR10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/09273940802056281","volume":"16","author":"KF Tabbara","year":"2008","unstructured":"Tabbara KF (2008) Nodular scleritis following alendronate therapy. Ocul Immunol Inflamm 16(3):99\u2013101","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"2035_CR11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/09273940902916111","volume":"17","author":"A Colucci","year":"2009","unstructured":"Colucci A, Modorati G, Miserocchi E, Di Matteo F, Rama P (2009) Anterior uveitis complicating zoledronic acid infusion. Ocul Immunol Inflamm 17(4):267\u2013268","journal-title":"Ocul Immunol Inflamm"},{"issue":"7","key":"2035_CR12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.SMJ.0000152753.80490.9F","volume":"98","author":"S Leung","year":"2005","unstructured":"Leung S, Ashar BH, Miller RG (2005) Bisphosphonate-associated scleritis: a case report and review. South Med J 98(7):733\u2013735, Review","journal-title":"South Med J"},{"issue":"4","key":"2035_CR13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4103\/0022-3859.37525","volume":"53","author":"V Raja","year":"2007","unstructured":"Raja V, Sandanshiv P, Neugebauer M (2007) Risedronate induced transient ocular myasthenia. J Postgrad Med 53(4):274\u2013275","journal-title":"J Postgrad Med"},{"issue":"5","key":"2035_CR14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/jop.2007.0046","volume":"23","author":"B Ramasamy","year":"2007","unstructured":"Ramasamy B, Quah S, Sahni JN, Palimar P (2007) Bilateral severe fibrinous anterior uveitis\u2014an unusual complication of pamidronate therapy exacerbated by topical latanoprost. J Ocul Pharmacol Ther 23(5):513\u2013515","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"2035_CR15","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1445-5994.1996.tb01932.x","volume":"26","author":"GO Stewart","year":"1996","unstructured":"Stewart GO, Stuckey BG, Ward LC, Prince RL, Gutteridge DH, Constable IJ (1996) Iritis following intravenous pamidronate. Aust N Z J Med 26(3):414\u2013415","journal-title":"Aust N Z J Med"},{"issue":"4","key":"2035_CR16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/ard.62.4.378","volume":"62","author":"P Fietta","year":"2003","unstructured":"Fietta P, Manganelli P, Lodigiani L (2003) Clodronate induced uveitis. Ann Rheum Dis 62(4):378","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2035-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-012-2035-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2035-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:57:21Z","timestamp":1559105841000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-012-2035-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,5]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["2035"],"URL":"https:\/\/doi.org\/10.1007\/s10067-012-2035-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,5]]}}}